Navigating medical documentation for abnormal lab findings requires pinpoint accuracy, especially when dealing with hepatic panels. The primary ICD-10-CM code for elevated liver function tests—specifically targeting transaminases—is R74.01, which covers elevation of levels of liver transaminase levels. You should apply this specific code when routine blood work shows high alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels, but the provider hasn't established a definitive underlying diagnosis yet.
Selecting the correct code prevents claim rejections and ensures patient charts accurately reflect pending clinical investigations. Misusing symptom codes for confirmed chronic conditions triggers audits and delays medical reimbursement. Let's break down when to use R74.01, alternative codes for broader abnormalities, and how to avoid costly billing errors.
Primary ICD-10 Code and Selection Criteria
The overarching category for abnormal serum enzyme levels in the ICD-10-CM manual is R74. Within this group, specific codes isolate exact biochemical markers.
- R74.01: Elevation of levels of liver transaminase levels. Use this when ALT, AST, or both test above the reference laboratory threshold without a confirmed root cause.
- R74.8: Other abnormal serum enzyme levels. Apply this for non-liver-specific enzyme elevations or isolated markers like alkaline phosphatase (ALP) when they don't map cleanly to transaminases.
- R94.5: Abnormal results of liver function studies. Use this broader code when multiple liver function tests are flagged as abnormal, but the clinical documentation doesn't isolate individual enzyme names.
According to the World Health Organization ICD-10 guidelines, symptom and sign codes should only describe encounters where a definitive diagnosis is still pending workup. If a patient gets blood work back showing mild transaminitis during an annual physical, you'll log R74.01 while ordering follow-up imaging or viral hepatitis panels.
When to Avoid R74.01: Confirmed Diagnoses
A frequent mistake in clinical billing is sticking with symptom codes after an etiology is found. Once a physician diagnoses a specific condition, you must drop R74.01 and code the definitive disease directly.
For example, if further diagnostic workup confirms non-alcoholic fatty liver disease (NAFLD), you switch the primary billing to K76.0 (Fatty liver, not elsewhere classified). If lab spikes stem from prescription medications, you'll code K71.0 through K71.9 (Toxic liver disease variants). Using a symptom code like R74.01 when a chronic condition is already documented leads to compliance flags from payers.
Coding Tip: Always cross-reference the lab report's specific reference ranges. Minor fluctuations just outside standard limits require careful chart review before assigning billable diagnostic codes.
Step-by-Step Documentation Workflow
Accurate billing starts inside the clinical note. If the chart lacks specific enzyme metrics, billers are forced to use vague fallback codes that invite denials. Follow this workflow to ensure clean claims:
- Review the Lab Panel: Check the patient chart for specific quantitative results for ALT, AST, and total bilirubin rather than trusting a vague note that just says "LFTs are high".
- Verify the Absence of a Definitive Diagnosis: Confirm that the attending physician has not tied the elevation to an active disease like alcoholic cirrhosis or acute hepatitis.
- Select R74.01 for Transaminases: If ALT or AST are elevated in isolation or combination without a known cause, assign R74.01.
- Append Secondary Manifestations: If the patient presents with physical symptoms like right upper quadrant pain, include R10.11 to build a complete clinical picture.
- Schedule Re-evaluation Coding: Update the code set on subsequent visits once repeat labs or ultrasounds yield a final diagnosis.
Common Coding Mistakes to Avoid
Medical coders and administrative staff often encounter friction when processing lab abnormalities. Watch out for these pitfalls:
- Using R94.5 for isolated ALT spikes: If only ALT is elevated, R74.01 is the accurate choice. R94.5 is reserved for broad, unspecific study abnormalities.
- Listing symptom codes as primary after diagnosis: Never sequence R74.01 ahead of a confirmed chronic liver pathology on outpatient claim forms.
- Omitting baseline reference numbers: Payers often audit high-cost diagnostic workups. Ensure the medical record includes the exact numerical lab value alongside the normal laboratory range.
For broader clinical context on reporting diagnostic standards, you can review guidelines provided by the Centers for Medicare & Medicaid Services. Clean documentation protects the practice from recoupment demands and keeps patient records transparent.
Frequently Asked Questions
Can I use R74.01 for elevated alkaline phosphatase?
No. R74.01 specifically covers transaminases (ALT and AST). Elevated alkaline phosphatase or gamma-glutamyl transferase (GGT) requires looking at alternative codes under the R74.8 category.
What happens if enzyme levels return to normal on the next test?
If repeat lab work shows liver enzymes have normalized, you don't need an ongoing chronic diagnosis code. The initial encounter is closed out using R74.01 to justify the diagnostic screening workup performed on that date.
Is R74.01 a billable ICD-10 code?
Yes, R74.01 is a fully billable and specific ICD-10-CM diagnosis code used across outpatient and inpatient settings when reporting abnormal transaminase findings.
When should I use toxic liver disease codes instead?
Switch to the K71 series if the physician documents that the enzyme elevation is a direct adverse reaction to a pharmaceutical drug, herbal supplement, or toxic substance exposure.
